Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
3	Mar 12, 2025	3
4	Mar 12, 2025	4
3	Mar 12, 2025	3
8-K	Mar 10, 2025	8-K
4	Mar 4, 2025	4
4	Mar 4, 2025	4
4	Mar 4, 2025	4
4	Mar 4, 2025	4
424B5	Mar 4, 2025	424B5
8-K	Mar 4, 2025	8-K
S-8	Mar 3, 2025	S-8
10-K	Mar 3, 2025	10-K
8-K	Feb 27, 2025	8-K
SCHEDULE 13G/A	Feb 14, 2025
8-K	Jan 10, 2025	8-K
8-K	Dec 16, 2024	8-K
SC 13G/A	Nov 14, 2024	SC 13G/A
SC 13G/A	Nov 14, 2024	SC 13G/A
SC 13G/A	Nov 14, 2024	SC 13G/A
SC 13G/A	Nov 14, 2024	SC 13G/A
10-Q	Nov 12, 2024	10-Q
8-K	Nov 12, 2024	8-K
SC 13G/A	Oct 18, 2024
4	Sep 30, 2024	4
4	Sep 30, 2024	4

← Newer Page 5 of 33 · 815 filings Older →